251 related articles for article (PubMed ID: 32349562)
1. The current reality of soft tissue sarcomas: advances, controversies, areas for improvement, and promising new treatments.
Blay JY; Le Cesne A; Demetri GD
Expert Rev Anticancer Ther; 2020 Apr; 20(sup1):29-39. PubMed ID: 32349562
[No Abstract] [Full Text] [Related]
2. Different approaches to advanced soft tissue sarcomas depending on treatment line, goal of therapy and histological subtype.
Martín-Broto J; Reichardt P; Jones RL; Stacchiotti S
Expert Rev Anticancer Ther; 2020 Apr; 20(sup1):15-28. PubMed ID: 32349558
[No Abstract] [Full Text] [Related]
3. A multidisciplinary approach to soft-tissue sarcoma of the extremities.
Nakayama R; Mori T; Okita Y; Shiraishi Y; Endo M
Expert Rev Anticancer Ther; 2020 Oct; 20(10):893-900. PubMed ID: 32820961
[TBL] [Abstract][Full Text] [Related]
4. Evolution in the management of soft tissue sarcoma: classification, surgery and use of radiotherapy.
Dei Tos AP; Bonvalot S; Haas R
Expert Rev Anticancer Ther; 2020 Apr; 20(sup1):3-13. PubMed ID: 32293209
[No Abstract] [Full Text] [Related]
5. Preclinical experimental therapeutic approaches in soft tissue sarcoma.
Hunt KK; Feig BW
Semin Surg Oncol; 1999; 17(1):78-82. PubMed ID: 10402641
[TBL] [Abstract][Full Text] [Related]
6. Current and advancing systemic treatment options for soft tissue sarcomas.
Harris SJ; Benson C; Jones RL
Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
[TBL] [Abstract][Full Text] [Related]
7. Establishing biomarkers for soft tissue sarcomas.
Czarnecka AM; Chmiel P; Błoński P; Rutkowski P
Expert Rev Anticancer Ther; 2024 Jun; 24(6):407-421. PubMed ID: 38682679
[TBL] [Abstract][Full Text] [Related]
8. Molecular targeted therapy for advanced or metastatic soft tissue sarcoma.
Yuan J; Li X; Yu S
Cancer Control; 2021; 28():10732748211038424. PubMed ID: 34844463
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
Italiano A; Dinart D; Soubeyran I; Bellera C; Espérou H; Delmas C; Mercier N; Albert S; Poignie L; Boland A; Bourdon A; Geneste D; Cavaille Q; Laizet Y; Khalifa E; Auzanneau C; Squiban B; Truffaux N; Olaso R; Gerber Z; Wallet C; Bénard A; Blay JY; Laurent-Puig P; Deleuze JF; Lucchesi C; Mathoulin-Pelissier S;
BMC Cancer; 2021 Nov; 21(1):1180. PubMed ID: 34740331
[TBL] [Abstract][Full Text] [Related]
10. Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.
Penel N; Coindre JM; Giraud A; Terrier P; Ranchere-Vince D; Collin F; Guellec SLE; Bazille C; Lae M; de Pinieux G; Ray-Coquard IL; Bonvalot S; Cesne ALE; Robin YM; Stoeckle E; Toulmonde M; Blay JY
Cancer; 2018 Mar; 124(6):1179-1187. PubMed ID: 29211310
[TBL] [Abstract][Full Text] [Related]
11. Advances and controversies in the management of soft tissue sarcomas.
Demetri GD; Blay JY; Casali PG
Future Oncol; 2017 Jan; 13(1s):3-11. PubMed ID: 27918199
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic considerations: how can we fine tune our approach to sarcoma?
Demicco EG; Lazar AJ
Semin Oncol; 2011 Oct; 38 Suppl 3():S3-18. PubMed ID: 22055969
[TBL] [Abstract][Full Text] [Related]
13. Novel Aspects of Genetics, Molecular Biology and Clinical Oncology of Sarcomas.
Houfková K; Hatina J
Klin Onkol; 2020; 33(1):66-78. PubMed ID: 32075391
[TBL] [Abstract][Full Text] [Related]
14. Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.
Gamboa AC; Gronchi A; Cardona K
CA Cancer J Clin; 2020 May; 70(3):200-229. PubMed ID: 32275330
[TBL] [Abstract][Full Text] [Related]
15. Malignant soft tissue tumors in children.
Thacker MM
Orthop Clin North Am; 2013 Oct; 44(4):657-67. PubMed ID: 24095080
[TBL] [Abstract][Full Text] [Related]
16. Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment.
Hogendoorn PC; Collin F; Daugaard S; Dei Tos AP; Fisher C; Schneider U; Sciot R;
Eur J Cancer; 2004 Jul; 40(11):1644-54. PubMed ID: 15251152
[TBL] [Abstract][Full Text] [Related]
17. First-Line Therapy for Metastatic Soft Tissue Sarcoma.
Meyer M; Seetharam M
Curr Treat Options Oncol; 2019 Jan; 20(1):6. PubMed ID: 30675651
[TBL] [Abstract][Full Text] [Related]
18. Emerging Targeted and Immune-Based Therapies in Sarcoma.
Pollack SM; Ingham M; Spraker MB; Schwartz GK
J Clin Oncol; 2018 Jan; 36(2):125-135. PubMed ID: 29220291
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for pediatric soft-tissue sarcomas.
Casanova M; Ferrari A
Expert Opin Pharmacother; 2011 Mar; 12(4):517-31. PubMed ID: 21306288
[TBL] [Abstract][Full Text] [Related]
20. Genetics of soft tissue tumors.
van de Rijn M; Fletcher JA
Annu Rev Pathol; 2006; 1():435-66. PubMed ID: 18039122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
